Net income of Neurocrine Biosciences under GAAP for the 3 months of 2022 was $13.9 million, down 2.3 times from $32.1 million in the previous year. Revenue increased 31.3% to $310.6 million compared to $236.6 million a year earlier.
Net income of Neurocrine Biosciences under GAAP for the 3 months of 2022 was $13.9 million, down 2.3 times from $32.1 million in the previous year. Revenue increased 31.3% to $310.6 million compared to $236.6 million a year earlier. 
neurocrine.gcs-web.com
English (US) 